Correlation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy.

Item

http://www.wikidata.org/entity/Q36153225

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Correlation Between Tumor Regr ...... Neoadjuvant Chemoradiotherapy.

@ast

Correlation Between Tumor Regr ...... Neoadjuvant Chemoradiotherapy.

@en

type

Item

label

Correlation Between Tumor Regr ...... Neoadjuvant Chemoradiotherapy.

@ast

Correlation Between Tumor Regr ...... Neoadjuvant Chemoradiotherapy.

@en

prefLabel

Correlation Between Tumor Regr ...... Neoadjuvant Chemoradiotherapy.

@ast

Correlation Between Tumor Regr ...... Neoadjuvant Chemoradiotherapy.

@en

P1476

Correlation Between Tumor Regr ...... Neoadjuvant Chemoradiotherapy.

@en

P2093

Chen-Kan Tseng

http://www.w3.org/2001/XMLSchema#string

Chi-Ju Yeh

http://www.w3.org/2001/XMLSchema#string

Chun-Bi Chang

http://www.w3.org/2001/XMLSchema#string

Hsien-Kun Chang

http://www.w3.org/2001/XMLSchema#string

Yu-Wen Wen

http://www.w3.org/2001/XMLSchema#string

Yun-Hen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Induction chemoradiotherapy and surgery for esophageal cancer: survival benefit with downstaging.

Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.

American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Oxygenation predicts radiation response and survival in patients with cervix cancer.

Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.

Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard.

P304

e1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000001407

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wen-Yu Chuang

Yin-Kai Chao

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26313788

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4602935

http://www.w3.org/2001/XMLSchema#string